Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
24,606
-1,458
-6% -$171K 0.46% 30
2026
Q1
$3.13M Buy
26,064
+1,126
+5% +$130K 0.52% 28
2025
Q4
$2.63M Sell
24,938
-2,356
-9% -$221K 0.43% 30
2025
Q3
$2.29M Buy
27,294
+9,885
+57% +$814K 0.36% 37
2025
Q2
$1.38M Buy
17,409
+792
+5% +$63K 0.22% 63
2025
Q1
$1.49M Buy
16,617
+849
+5% +$79.3K 0.25% 54
2024
Q4
$1.57M Buy
15,768
+808
+5% +$83.3K 0.27% 49
2024
Q3
$1.7M Buy
14,960
+81
+0.5% +$9.62K 0.32% 45
2024
Q2
$1.84M Buy
14,879
+406
+3% +$52.3K 0.42% 31
2024
Q1
$1.91M Sell
14,473
-5
-0% -$616 0.43% 29
2023
Q4
$1.58M Sell
14,478
-384
-3% -$39.9K 0.37% 38
2023
Q3
$1.53M Buy
14,862
+395
+3% +$42.6K 0.4% 34
2023
Q2
$1.67M Buy
14,467
+694
+5% +$78.8K 0.43% 33
2023
Q1
$1.47M Sell
13,773
-5,292
-28% -$571K 0.39% 33
2022
Q4
$2.12M Buy
19,065
+5,423
+40% +$554K 0.54% 18
2022
Q3
$1.18M Buy
13,642
+4,053
+42% +$362K 0.34% 21
2022
Q2
$874K Buy
9,589
+5,665
+144% +$502K 0.24% 23
2022
Q1
$322K Buy
+3,924
New +$309K 0.08% 30

Other funds holding MRK

Matrix Trust Company's MRK Position: Q2 2026 in Review

Matrix Trust Company reduced its Merck (MRK) stake by 5.6% in Q2 2026, selling an estimated $171K and leaving 24,606 shares worth $3.16M. The position accounts for 0.46% of the portfolio, ranked #30.

Matrix Trust Company first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Matrix Trust Company held 24,606 shares of Merck worth $3.16M as of Q2 2026.
  • Matrix Trust Company sold 1,458 Merck shares in Q2 2026, an estimated $171K.
  • Merck made up 0.46% of Matrix Trust Company's portfolio in Q2 2026, its #30 holding.
  • Matrix Trust Company first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Matrix Trust Company's 13F filing for Q2 2026, filed 9 Jul 2026.